28 results
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
for rebates, chargebacks, other customer fees and returns, which are recognized in Accrued expenses and other current liabilities as set out in the Company’s … on the location of the end customer below (in thousands).
Three Months Ended March 31,
United States
Europe
International
Total product revenue, net
Product
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
by country / region based on the location of the customer below.
United States
Europe
International
Total revenue from the sale of therapies … have been rare. If the failure rate increased substantially, we could experience increased costs, lost revenue, damage to customer relations, time
6-K
EX-99.2
IMCR
Immunocore Holdings plc
7 Nov 23
Current report (foreign)
7:09am
that control transfers to a customer, which is typically on delivery to our distributors and healthcare providers. We also operate under consignment … to which we expect to be entitled, net of estimated deductions for rebates, chargebacks, other customer fees and product returns. These estimates
6-K
EX-99.1
IMCR
Immunocore Holdings plc
7 Nov 23
Current report (foreign)
7:09am
of a compassionate use and early access program are presented by region based on the location of the customer below.
For the Three Months Ended
September 30 … is presented after estimated deductions for rebates, chargebacks, other customer fees and returns.
Pre-product revenue, net
There was no pre-product
6-K
EX-99.1
IMCR
Immunocore Holdings plc
10 Aug 23
Current report (foreign)
8:28am
from the sale of tebentafusp as part of a compassionate use and early access program are presented by region based on the location of the customer below … . Revenue is presented after estimated deductions for rebates, chargebacks, other customer fees and returns.
Pre-product revenue, net
There was no pre
6-K
EX-99.2
uifycte
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.1
v9tsoyox5xijh05z
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.2
veqt3788
10 May 23
Current report (foreign)
7:27am
6-K/A
EX-99.1
mh8xqnv
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.2
17q ewgjz
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
y90xkf1cirnii6pxp6lx
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
7t2950h3xfq1wdb htzv
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.2
xn9k 4i6o
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
u719infs9b 7t
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
76zaiepyjr
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.2
bg2x y5ajm
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.1
ck133ek0dx13a8uf
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
EX-99.1
ajcvqwhf ccizijg
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
20-F
8k21arkdvg
25 Mar 21
Annual report (foreign)
7:01am